Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,347,799 | 801,695 | 792,739 | 942,261 | 1,442,232 |
| Depreciation Amortization | 1,697,563 | 1,885,296 | 1,896,158 | 1,936,899 | 1,920,971 |
| Income taxes - deferred | -30,789 | -78,638 | -132,202 | -43,694 | 79,574 |
| Accounts receivable | -78,136 | -79,510 | -164,341 | -49,184 | -193,078 |
| Accounts payable and accrued liabilities | 30,790 | -49,993 | -11,803 | -9,194 | 23,302 |
| Other Working Capital | 156,403 | 480,791 | 607,469 | -134,931 | -115,669 |
| Other Operating Activity | -90,348 | -377,596 | -142,870 | -358,606 | -212,007 |
| Operating Cash Flow | $3,033,282 | $2,582,046 | $2,845,151 | $2,283,551 | $2,945,325 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,016,760 | -741,514 | -723,472 | -724,648 | -981,897 |
| Net Acquisitions | 203,842 | 656,492 | 148,274 | 1,083 | -451,621 |
| Purchase Of Investment | -99,021 | -88,192 | -110,788 | -111,303 | -152,716 |
| Sale Of Investment | 94,469 | 81,303 | 96,969 | 60,762 | 170,977 |
| Investing Cash Flow | $-817,471 | $-91,913 | $-589,017 | $-774,106 | $-1,415,257 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 177,016 | 91,775 | 70,714 | 755,530 | 2,134,557 |
| Debt Issued | 1,835,756 | 66,563 | 452,268 | 1,039,821 | 1,471,888 |
| Debt Repayment | -949,907 | -902,971 | -758,328 | -784,532 | -2,464,397 |
| Common Stock Issued | N/A | N/A | N/A | 21,233 | 7,703 |
| Common Stock Repurchased | -662,192 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,127,424 | -717,273 | -694,824 | -740,652 | -860,468 |
| Other Financing Activity | -860,838 | -1,318,334 | -1,081,317 | -1,995,452 | -1,501,230 |
| Financing Cash Flow | $-1,587,588 | $-2,780,240 | $-2,011,486 | $-1,704,051 | $-1,211,946 |
| Exchange Rate Effect | -160,067 | 28,349 | -78,583 | -24,404 | 155,256 |
| Beginning Cash Position | 1,341,080 | 1,544,400 | 1,378,620 | 1,561,072 | 1,279,569 |
| End Cash Position | 1,809,236 | 1,282,643 | 1,544,686 | 1,342,062 | 1,752,946 |
| Net Cash Flow | $468,156 | $-261,757 | $166,066 | $-219,010 | $473,377 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,033,282 | 2,582,046 | 2,845,151 | 2,283,551 | 2,945,325 |
| Capital Expenditure | -1,035,648 | -756,775 | -740,938 | -762,794 | -1,010,793 |
| Free Cash Flow | 1,997,634 | 1,825,271 | 2,104,213 | 1,520,757 | 1,934,532 |